BioNTech SE American Depositary Share (BNTX)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 17, 2022 | $2.13 | 2022-06-02 | 2022-06-03 |
Dividends Summary
- BioNTech SE American Depositary Share has issued 1 dividend payments over the past 0 years
- The most recent dividend was paid 1191 days ago, on June 17, 2022
- The highest dividend payed out to investors during this period was $2.1322 per share
- The average dividend paid during this period was $2.13 per share.
Company News
The global cell therapy market is projected to grow from $5.88 billion in 2024 to $44.39 billion by 2034, driven by rising demand for regenerative medicine, advancements in biotechnology, and increasing prevalence of chronic diseases.
The Washington Post reported that government officials may link 25 children's deaths to coronavirus vaccines, causing BioNTech's stock to decline by 7% amid potential negative findings to be presented to a CDC advisory panel.
BioNTech and Bristol Myers Squibb reported encouraging interim results for Pumitamig, a bispecific antibody candidate targeting PD-L1 and VEGF-A, in treating advanced small cell lung cancer. The Phase-2 study showed a 76.3% confirmed objective response rate and 100% disease control rate, suggesting potential for a new standard of care.
While smaller deals have been completed, including overseas acquisitions, the expected surge in large-scale mergers and acquisitions has not materialized. Factors like trade policy uncertainty and economic concerns have kept corporate decision-makers cautious about striking major deals.
Pfizer is expected to report Q2 2024 earnings on July 30, with consensus estimates of $13.22 billion in sales and $0.45 per share. While COVID-19 product sales are expected to decline, key non-COVID drugs like Prevnar, Vyndaqel, and Eliquis are likely to provide top-line support. The company's recent acquisitions and new product launches are also expected to contribute to the results.